Keryx Biopharmaceuticals (KERX)

Add to Watchlists
Create an Alert
14.79 +0.12  +0.85% NASDAQ Dec 19, 8:00PM BATS Real time Currency in USD
View Full Chart
KERX Price Chart
View All Events

KERX Events

Date Type Description
11/06/2014 08:00 EST Misc Q3 2014 Keryx Biopharmaceuticals, Inc. Earnings Conference Call
11/06/2014 Earnings Q3 2014 Keryx Biopharmaceuticals, Inc. Earnings Results
08/07/2014 08:00 EDT Misc Keryx Biopharmaceuticals Inc Q2 2014 Earnings Conference Call
08/07/2014 Earnings Keryx Biopharmaceuticals Inc Q1 2014 Earnings Results
06/23/2014 Misc Annual General Meeting for Keryx Biopharmaceuticals Inc
05/08/2014 08:00 EDT Misc Keryx Biopharmaceuticals Inc Q1 2014 Earnings Conference Call
05/08/2014 Earnings Keryx Biopharmaceuticals Inc Q1 2014 Earnings Results
03/13/2014 08:30 EDT Misc Q4 2013 Keryx Biopharmaceuticals, Inc. Earnings Conference Call
03/13/2014 Earnings Q4 2013 Keryx Biopharmaceuticals, Inc. Earnings Results
View All Performance Charts

KERX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Keryx Biopharmaceuticals is up 10.70% over the last year vs S&P 500 Total Return up 16.79%, AMAG Pharmaceuticals up 90.55%, and Puma Biotechnology up 120.6%.

Get Quote for

PDF Report for KERX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download KERX Pro Report PDF
Advertisement

Portfolio Strategies Featuring KERX

Did Keryx Biopharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

KERX Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.keryx.com
  • IR Website: http://www.keryx.com/investor-relations/
  • HQ Country: United States
  • HQ State/Province: New York
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: December 31, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: September 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • Next Earnings Release: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Keryx Biopharmaceuticals, Inc., is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of renal disease. It is developing ZerenexTM an oral, ferric iron-based compound.

KERX Excel Add-In Codes

  • Name: =YCI("KERX","name")
  • Description: =YCI("KERX","description")
  • Sector: =YCI("KERX","sector")
  • Industry: =YCI("KERX","industry")
  • Est. Current Fiscal Year End: =YCI("KERX","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.